Results 161 to 170 of about 24,656 (219)
Some of the next articles are maybe not open access.
Annals of Internal Medicine, 1983
Excerpt To the editor: The observation by Gavras and Gavras (1) that four patients with adverse reactions while on Captopril subsequently had no reactions when enalapril was substituted is interest...
I, Gavras, H, Gavras
openaire +4 more sources
Excerpt To the editor: The observation by Gavras and Gavras (1) that four patients with adverse reactions while on Captopril subsequently had no reactions when enalapril was substituted is interest...
I, Gavras, H, Gavras
openaire +4 more sources
International Journal of Pharmaceutics, 1992 Assay procedures based on derivative spectrophotometry have been developed for the determination of captopril alone or in combination with hydrochlorothiazide in tablets.
Irène Panderi
exaly +1 more source
Clinical Pharmacology and Therapeutics, 1982
Captopril, an angiotensin-converting enzyme inhibitor with antihypertensive properties, was given by mouth and intravenously in 10-mg doses to five healthy subjects. After intravenous dosing, semilogarithmic plots of captopril blood levels : time showed a triexponential decay. Data were analyzed using an open three-compartment model. The average volume
K L, Duchin +4 more
openaire +2 more sources
Captopril, an angiotensin-converting enzyme inhibitor with antihypertensive properties, was given by mouth and intravenously in 10-mg doses to five healthy subjects. After intravenous dosing, semilogarithmic plots of captopril blood levels : time showed a triexponential decay. Data were analyzed using an open three-compartment model. The average volume
K L, Duchin +4 more
openaire +2 more sources
Effect of captopril on mushroom tyrosinase activity in vitro
BBA - Proteins and Proteomics, 2001 12 pages, 10 figures.The study presented here demonstrates that the antihypertensive drug captopril ([2S]-N-[3-mercapto-2-methylpropionyl]- -proline) is an irreversible non-competitive inhibitor and an irreversible competitive inhibitor of the ...
Juan CARLOS Espin, Harry J Wichers
exaly +2 more sources
The FASEB Journal, 2003
Over the past few years, and particularly recently, there has been a goodly amount of discussion in the press about the discovery and development of highly successful drugs by the pharmaceutical industry, in which extensive data generated by government-sponsored research is claimed to have played a significant role in the industry’s success.
Charles G, Smith, John R, Vane
openaire +2 more sources
Over the past few years, and particularly recently, there has been a goodly amount of discussion in the press about the discovery and development of highly successful drugs by the pharmaceutical industry, in which extensive data generated by government-sponsored research is claimed to have played a significant role in the industry’s success.
Charles G, Smith, John R, Vane
openaire +2 more sources
JAMA: The Journal of the American Medical Association, 1984
To the Editor.— In the Jan 20 issue ofThe Journal, Dr Zatuchni 1 reports a case of pericarditis that he contends was caused by captopril therapy. There are several points that must be made. The author's case presentation is incomplete. Only in the last sentence does he state that "the serum urea nitrogen level continued to rise." How high was this ...
openaire +2 more sources
To the Editor.— In the Jan 20 issue ofThe Journal, Dr Zatuchni 1 reports a case of pericarditis that he contends was caused by captopril therapy. There are several points that must be made. The author's case presentation is incomplete. Only in the last sentence does he state that "the serum urea nitrogen level continued to rise." How high was this ...
openaire +2 more sources
2000
Abstract Captopril is an angiotensin-converting enzyme (ACE) in hibitor widely used in treatment of essential hypertension. It is considered safe and effective; principal systemic toxic reactions center around sudden decreases in blood pressure associated with commencement of therapy.
openaire +1 more source
Abstract Captopril is an angiotensin-converting enzyme (ACE) in hibitor widely used in treatment of essential hypertension. It is considered safe and effective; principal systemic toxic reactions center around sudden decreases in blood pressure associated with commencement of therapy.
openaire +1 more source